NY Medical Midtown, Igor Kletsman MD

For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Nearby Clinics

New York, NY

Peptides & Treatments

About

NY Medical Midtown operates under the direction of Igor Kletsman, MD, a physician holding dual board certifications in Family Medicine and Integrative Medicine, delivering peptide-based therapies and metabolic interventions to patients throughout New York, NY. Dr. Kletsman's dual certification framework allows the practice to address acute primary care needs while simultaneously implementing advanced protocols for weight management and hormonal balance, a combination that distinguishes this Midtown clinic from conventional family medicine offices. The practice maintains in-person consultation availability, enabling Dr. Kletsman and his clinical team to conduct comprehensive physical assessments, order onsite laboratory work, and adjust treatment protocols based on real-time patient response rather than relying solely on remote monitoring.

The clinic's peptide and metabolic therapy menu centers on three primary agents: NAD+ infusions for cellular energy restoration and neuroprotection, Semaglutide for GLP-1 receptor agonism in weight reduction programs, and Tirzepatide, a dual GIP/GLP-1 receptor agonist offering enhanced glycemic control and appetite regulation. Semaglutide protocols at NY Medical Midtown typically begin with subcutaneous dosing at 0.25 mg weekly, titrating upward based on tolerance and weight loss velocity, while Tirzepatide programs start at 2.5 mg weekly with similar escalation pathways. NAD+ administration occurs via intravenous infusion, with treatment frequencies ranging from weekly to monthly depending on whether the patient seeks cognitive support, metabolic enhancement, or recovery from chronic fatigue states. Dr. Kletsman's integrative medicine certification informs his approach to combining these peptides with nutritional counseling, micronutrient optimization, and lifestyle modification strategies rather than prescribing pharmacotherapy in isolation.

Dr. Kletsman's clinical philosophy integrates his family medicine foundation with functional and integrative principles, meaning patients receive continuity of care that spans from annual physicals and acute illness management to specialized peptide protocols and hormone replacement. His board certification in Integrative Medicine reflects formal training in evidence-based complementary modalities, nutrient therapeutics, and mind-body medicine, which he applies when designing individualized treatment plans for metabolic dysfunction, andropause, perimenopause, and age-related decline. The nursing staff at NY Medical Midtown handles phlebotomy, vital sign monitoring, and patient education regarding injection technique for at-home peptide administration, while the front desk coordinates insurance verification, prior authorizations for GLP-1 medications, and follow-up laboratory scheduling to track biomarkers such as hemoglobin A1c, lipid panels, and hormone levels throughout treatment.

Patients presenting for weight loss consultations at NY Medical Midtown undergo initial assessments that include body composition analysis, metabolic rate evaluation, and screening for underlying endocrine disorders such as hypothyroidism or insulin resistance before Dr. Kletsman recommends Semaglutide or Tirzepatide. Hormone optimization programs begin with comprehensive panels measuring total and free testosterone, estradiol, progesterone, DHEA-S, and thyroid function, followed by bioidentical hormone replacement or peptide adjuncts depending on deficiency patterns and patient goals. The practice's preventive care framework incorporates cardiovascular risk stratification, cancer screening adherence, and metabolic syndrome reversal strategies, positioning peptide therapy as one component within a broader health optimization model rather than a standalone intervention. Follow-up visits occur at intervals determined by treatment type—GLP-1 agonist patients typically return every four weeks during dose titration, while NAD+ recipients may schedule monthly or quarterly based on symptom resolution and energy restoration.

NY Medical Midtown's Midtown Manhattan location provides access to patients across the five boroughs and surrounding New York metropolitan area, with the in-person consultation model allowing Dr. Kletsman to perform physical examinations, assess injection site reactions, and modify protocols based on clinical findings that telehealth platforms cannot capture. The practice accepts various insurance plans for primary care services and conducts eligibility verification for Semaglutide and Tirzepatide coverage, though patients should anticipate out-of-pocket costs for peptides not covered by their specific plan formularies. The onsite laboratory capability enables same-visit blood draws with results integrated directly into treatment planning, reducing the delays associated with external lab referrals and allowing Dr. Kletsman to initiate or adjust peptide dosing based on current metabolic and hormonal data rather than outdated values.

Care Team

Igor Kletsman· MD

Our Team

Igor Kletsman, MD

Lead Physician

Board Certified in Family Medicine and Integrative Medicine. Your healthcare partner, committed to optimizing your long-term health and managing your care across specialties.

Topics Mentioned in Reviews

Patient Reviews

Services Offered

NAD+ Injections

Restore Vitality at the Cellular Level

Weight Loss with GLP Medications

A Modern, Medical Approach to Sustainable Weight Loss

Growth Hormone Therapy

Restore Youthful Vitality Safely

FAQ

MyPeptideMatch.com is an independent directory. We do not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Inflammation reduction versus fat reduction: which matters more?

This is the question that the Italian exenatide study highlighted so powerfully. Case 1 lost no weight but still experienced pain reduction and measurable changes in subcutaneous fat thickn…

Source: seekpeptides.com

comparison

Keto supplements versus GLP-1 medications: they are not the same thing

This distinction requires absolute clarity because confusion here can be dangerous. Exogenous ketone supplements, MCT oil products, and "keto pills" sold over the counter are NOT GLP-1 rece…

Source: seekpeptides.com

Research context

Read sources and limitations before applying a claim.

Hope or Hype? Evaluating the Evidence

The excitement around peptide therapy reflects a desire for safer, more targeted treatments. Early studies suggest peptides can modulate immune responses, promote tissue repair, and improve gut integrity. However, most evidence comes from animal models or small human trials. There is a lack of large randomized clinical studies evaluating the effectiveness in autoimmune diseases. Without robust data, it is hard to distinguish hope from hype. Peptides are not magic bullets. They may provide incremental benefits when used appropriately and under supervision. Overblown claims and self‑administration can lead to disappointment or harm. When evaluating peptides, consider the quality of evidence, personal health history, and your healthcare provider’s guidance. Ask whether there are published studies, what outcomes were measured, and whether results apply to your condition. Remain cautious of marketing that promises cures or uses pseudoscience. Balanced optimism will help you navigate the emerging field of peptide therapy.

Source: livvnatural.com ↗

Peptide Therapy: What Doctors Actually Prescribe vs. What's Being Marketed Without Evidence

Reviewed by Yoshinori Abe, MD Internal Medicine Only a few peptides are FDA-approved and prescribed by licensed physicians, each backed by rigorous clinical trials: Teriparatide and abaloparatide — treat osteoporosis Bremelanotide — treats low sexual desire IGF-1 — treats rare growth disorders GLP-1 agonists (semaglutide, tirzepatide) — treat type 2 diabetes and support weight management Many other peptides sold online make bold claims but lack human clinical data, standardized dosing, and verified safety profiles. Approved uses, off-label risks, and legal concerns all matter when weighing your options. Unsure whether peptide therapy fits your symptoms or health goals? Before pursuing unverified products or booking appointments, take a free, instant, online symptom check to identify what may actually be driving your concerns. In just minutes, you'll receive evidence-based guidance on smart next steps — whether that's a proven peptide, an alternative treatment, or a focused conversation with your doctor — so you can avoid wasted time, money, and risk. Reviewed for medical accuracy: 06/17/2026

Source: ubiehealth.com ↗

Practical and safety references

These excerpts are educational, not personalised medical instructions.

Potential benefits

What Are the Benefits of Peptide Therapy in Maricopa, AZ?

Peptide therapy offers a multitude of benefits, making it a versatile treatment option for various health concerns. Here are some of the key advantages:

Source: nulevelwellnessmedspa.com ↗

Side effects

Gastrointestinal side effects compound the problem

Nausea affects 44% of semaglutide users and 28% of tirzepatide users in clinical trials. Vomiting hits 24% and 13% respectively. Diarrhea affects 30% and 23%. These are not minor inconveniences. Each episode of vomiting or diarrhea strips nutrients from your body before they can be absorbed. When you are already eating less, losing nutrients through GI side effects creates a double hit. Your intake is down and your losses are up. This is why the first few months of GLP-1 therapy, when side effects are most common and dose titration is happening, represent the highest risk period for developing deficiencies. Constipation, which affects roughly one in four users, presents its own challenges. While it does not directly cause nutrient loss, it often leads people to reduce fiber intake further, which compounds the problem of inadequate nutrition.

Source: seekpeptides.com ↗

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →